Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
CapEx to Revenue
0.94%
TTM · Retrieved:
LCTX CapEx to Revenue
Current (TTM)0.94%retrieved
Current (TTM)0.94%retrieved
LCTX TTM CapEx/Revenue (0.94% → 0.94%)
Latest values, visible window
More history is needed to export this chart.
LCTX capex to revenue history
Published TTM snapshot. The date records when this current TTM value was retrieved.
| Retrieved | CapEx to Revenue |
|---|---|
| 0.9402% |